Paediatric Multidrug Resistant Tuberculosis Outbreak in a Low Incidence Country: The Need for Better Diagnosic Tools and More Accessible Treatments

Arch Bronconeumol. 2023 Mar;59(3):183-185. doi: 10.1016/j.arbres.2022.11.013. Epub 2022 Nov 30.

[Article in English, Spanish]

Authors

Francesc Arasa Panisello¹, Berta Soler Febrer², Ana Maria Isabel Lima Cordón², Nelly Raquel García López², Elena Martínez García², Antoni Soriano-Arandes³

Affiliations

¹ Pediatrics Service. Hospital de Tortosa Verge de la Cinta, ICS, Tortosa, Catalonia, Spain. Electronic address: arasafrancesc@gmail.com.
² Pediatrics Service. Hospital de Tortosa Verge de la Cinta, ICS, Tortosa, Catalonia, Spain.
³ Paediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, ICS, Barcelona, Catalonia, Spain.

PMID: 36517312
DOI: 10.1016/j.arbres.2022.11.013

No abstract available

Publication types

Case Reports

MeSH terms

Antitubercular Agents / therapeutic use
Child
Disease Outbreaks
Humans
Incidence
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

Antitubercular Agents